138 related articles for article (PubMed ID: 15953086)
1. HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy.
Urosevic M; Kempf W; Zagrodnik B; Panizzon R; Burg G; Dummer R
Clin Exp Dermatol; 2005 Jul; 30(4):422-5. PubMed ID: 15953086
[TBL] [Abstract][Full Text] [Related]
2. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?
Kooy AJ; Prens EP; Van Heukelum A; Vuzevski VD; Van Joost T; Tank B
J Pathol; 1999 Feb; 187(3):351-7. PubMed ID: 10398091
[TBL] [Abstract][Full Text] [Related]
4. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
5. [Expression of HLA-class I and II antigens on basal cell carcinoma].
Nakamura T; Kageshita T; Hirai S; Kimura T; Yoshii A; Ono T; Arao T
Nihon Hifuka Gakkai Zasshi; 1990 Dec; 100(14):1431-5. PubMed ID: 2082044
[TBL] [Abstract][Full Text] [Related]
6. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
7. HLA-G in the skin--friend or foe?
Urosevic M
Semin Cancer Biol; 2007 Dec; 17(6):480-4. PubMed ID: 17981049
[TBL] [Abstract][Full Text] [Related]
8. The expression of p63 in basal cell carcinomas and association with histological differentiation.
Bircan S; Candir O; Kapucoglu N; Baspinar S
J Cutan Pathol; 2006 Apr; 33(4):293-8. PubMed ID: 16630179
[TBL] [Abstract][Full Text] [Related]
9. Structure, expression and function of HLA-G in renal cell carcinoma.
Seliger B; Schlaf G
Semin Cancer Biol; 2007 Dec; 17(6):444-50. PubMed ID: 17707652
[TBL] [Abstract][Full Text] [Related]
10. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Am J Clin Pathol; 2007 Dec; 128(6):1002-9. PubMed ID: 18024326
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of basal cell carcinomas: an audit of current practice.
Mc Loone NM; Tolland J; Walsh M; Dolan OM
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of computer-assisted morphological and morphometrical analysis for detecting the recurrence tendency of basal cell carcinoma.
Cheretis C; Angelidou E; Dietrich F; Politi E; Kiaris H; Koutselini H
Med Sci Monit; 2008 May; 14(5):MT13-19. PubMed ID: 18443558
[TBL] [Abstract][Full Text] [Related]
13. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments.
Hernández-Machin B; Borrego L; Gil-García M; Hernández BH
Int J Dermatol; 2007 May; 46(5):453-9. PubMed ID: 17472670
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
Levy EM; Bianchini M; Von Euw EM; Barrio MM; Bravo AI; Furman D; Domenichini E; Macagno C; Pinsky V; Zucchini C; Valvassori L; Mordoh J
Int J Oncol; 2008 Mar; 32(3):633-41. PubMed ID: 18292941
[TBL] [Abstract][Full Text] [Related]
15. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
[TBL] [Abstract][Full Text] [Related]
16. Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.
Freier K; Flechtenmacher C; Devens F; Hartschuh W; Hofele C; Lichter P; Joos S
Oncol Rep; 2006 May; 15(5):1141-5. PubMed ID: 16596176
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
18. Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
Wischhusen J; Waschbisch A; Wiendl H
Semin Cancer Biol; 2007 Dec; 17(6):459-68. PubMed ID: 17768067
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy-induced basal cell carcinomas of the scalp: are they genetically different?
Tessone A; Amariglio N; Weissman O; Jacob-Hirsch J; Liran A; Stavrou D; Haik J; Orenstein A; Winkler E
Aesthetic Plast Surg; 2012 Dec; 36(6):1387-92. PubMed ID: 23052377
[TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma: expression of HLA-G.
Adithi M; Kandalam M; Ramkumar HL; Subramanian A; Venkatesan N; Krishnakumar S
Ocul Immunol Inflamm; 2006 Aug; 14(4):207-13. PubMed ID: 16911982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
